Skip to main content
Home/Stacks/Hollywood Body Composition Stack
GROWTH STACK

Hollywood Body Composition Stack

Tesamorelin + Ipamorelin - the GHRH + GHRP body-composition combination researched by high-performance users.

Educational overview only - not medical advice. No compound in this stack is presented as a treatment for any condition. Any protocol decision is a conversation with your licensed healthcare provider.

About This Stack

The Hollywood Stack is the body-composition-focused variant of the GH Axis Stack. It pairs Tesamorelin (FDA-approved GHRH analog for HIV-associated lipodystrophy) with Ipamorelin (clean GHRP) to drive a stronger IGF-1 response than either alone.

The combination is researched by high-performance users - athletes, executives, media-facing professionals - pursuing visceral-fat reduction and recomposition. Tesamorelin has the strongest published evidence for visceral adiposity specifically, which is why it anchors this stack.

No compound here is presented as a treatment for any condition except Tesamorelin's on-label indication. Body-composition goals are a conversation with a provider who can rule out the metabolic and hormonal factors that often drive them.

Why These Compounds Are Researched Together

Tesamorelin is a stabilized GHRH analog with the strongest published visceral-fat-reduction data in the GH-peptide class. Ipamorelin is a GHRP (ghrelin-receptor agonist) that provides a clean GH pulse via a different receptor. Pairing the two produces synergistic IGF-1 elevation - the GHRH signal plus the GHRP signal converge on the same pituitary output.

Compounds in the Hollywood Body Composition Stack

TesamorelinGHRH ANCHOR
Tesamorelin (Egrifta)
FDA-approved GHRH analog with strongest visceral-fat-reduction data in the class.
IpamorelinGHRP SYNERGIST
Ipamorelin
Clean GHRP pulse on the ghrelin receptor - synergistic with tesamorelin's GHRH signal.

Biomarkers Users Commonly Track

When running a stack like this, these biomarkers let users see how the compounds perform in context. Trended across draws, they reveal whether the stack is actually moving the markers it should - or producing unintended shifts that warrant a provider conversation.

GROWTH
IGF-1
Primary GH-axis response marker. Tesamorelin typically drives 40–80% rise from baseline; non-response at 6 weeks usually points to compliance or technique.
METABOLIC
Fasting Insulin
Catches insulin-resistance drift months before HbA1c moves; the earliest warning sign on GH-elevating protocols.
METABOLIC
HbA1c
Quarterly glycemic check - GH elevation has metabolic consequences over months.
CARDIOVASCULAR
ApoB
Cardiovascular marker - body-composition goals should not come at cardiovascular cost. Track quarterly.
HORMONE
Total Testosterone
Baseline hormone panel - low T often underlies stubborn recomposition and is a higher-leverage fix than peptides.
HORMONE
Free Testosterone
Bioavailable testosterone - often more informative than total when SHBG is abnormal. Critical for recomp protocols.
HORMONE
SHBG
Carrier protein that determines free testosterone availability. Insulin resistance suppresses SHBG; a low SHBG with normal total T can still produce hypogonadal symptoms.

Typical Cycle

Tesamorelin cycles of 12–26 weeks are common in community reports. Ipamorelin runs alongside. Cycling is a provider conversation.

What to Discuss With Your Provider

Body-composition complaints often trace to thyroid, low testosterone, poor sleep, or dietary patterns. A provider should rule these out first - they are higher-leverage than any peptide protocol.

Related Stacks

GROWTH
Growth Hormone Axis Stack
Ipamorelin + CJC-1295 - the GHRP + GHRH pairing users research for physiologic GH pulse restoration.
LONGEVITY
Longevity Core Stack
Epithalon + BPC-157 + GHK-Cu - the foundational long-cycle combination users research for cellular aging and systemic repair.
Track the Hollywood Body Composition Stack against your labs.

Log every compound in the stack, upload your lab PDFs, and chart the biomarkers on this page across every draw. StackAI reads the panel in context of what you’re running.

Start tracking free →
Compliance notice: This page is informational and educational only. MyProtocolStack does not provide medical advice, diagnosis, or treatment. All references to compounds describe what users research and typically discuss with their clinician - not endorsements, prescriptions, or treatment recommendations. Research-stage compounds discussed are not FDA-approved unless specifically noted. Any protocol decision requires a licensed healthcare provider.